Skip to main content
. 2021 Mar 8;21:114. doi: 10.1186/s12887-021-02583-6

Table 2.

Short-term Neurological and CA of 18 months Neurodevelopmental Outcome

Control (n = 49) I (n = 45) P-value P-value§
HC at PMA 36 weeks (z-score) −1.45 (−3.92, 0.51) −2.12 (−5.28, 0.17) < 0.001* 0.049*
aEEG at PMA 35 weeks
 Maturation score 9.50 (4, 13) 8 (4, 12) 0.002* 0.017*
WMI on MRI at discharge 0.008* 0.036*
 None 48 (98) 33 (73.3)
 Mild 1 (2) 8 (17.8)
 Moderate to severe 0 (0) 4 (8.9)
HC at a CA of 18 months (z-score) 0.32 (−2.42, 2.36) − 0.88 (−3.91, 2.13) < 0.001* 0.005*
Bayley-III and Cerebral palsy at a CA of 18 months
 Cognitive 95 (85, 125) 90 (55, 120) 0.006* 0.076
 Language 97 (74, 121) 89 (50, 121) 0.015* 0.108
 Motor 100 (82, 118) 91 (46, 110) 0.002* 0.029*
 Social Emotional 95 (80, 110) 90 (55, 115) 0.066 0.311
 Adaptive Behaviour 92 (61, 115) 84 (48, 111) 0.005* 0.055
 Cerebral palsy 2 (4.0) 6 (13.3) 0.080 0.240

Values are presented as average (min, max), or number (%)

P-values are adjusted for gestational age

§P-values are adjusted for gestational age, Apgar score, RDS, BPD, PDA operation, ROP (≥stage III), and IVH (≥Grade III)

HC head circumference; aEEG amplitude-integrated EEG; PMA Postmenstrual age; WMI White matter injury; MRI magnetic resonance imaging; CA corrected age, Bayley-III Bayley Scales of Infant and Toddler Development III

* p < 0.05